Dear Colleagues and friends
It is estimated that 30% of diseases caused by mutations can be linked to splicing. Mutation of a splice site can result in site loss of function and specificity, causing insertion or deletion of aminoacids or a disruption of the reading frame. The importance of understanding and properly decoding roles governing splicing have become a fact for the research community as demonstarted by the increasing number of manuscripts devoted to this subject. Splicing 2023 intends to join in a friendly academic environment all of us working or interested in moving to this area of research. The conference will take place in summer in one of the best beach areas from Portugal, the sea village of Caparica (South Lisbon area). We aim you to present your latest results in Splicing and to join the best researchers in this area of knowledge. Please do not hesitate in contacting me should you have any suggestion to help us make of this event a remarkable one.
Yours truly
C. Lodeiro
J. L. Capelo
Conference chairs
On behalf of the organizing and scientific committee
Plenary Speakers
John Rasko, PhD
Head of Department, Cell & Molecular Therapies, Royal Prince Alfred Hospital, Sydney (Australia)
Steve Wilton, PhD
Murdoch University (Australia)
Ruth Sperling, PhD
Department of Genetics, The Hebrew University of Jerusalem, Jerusalem (Israel)
Lorna Harries, PhD
University of Exeter Medical School, Exeter (UK)
Raymond Kaempfer, PhD
Biochemistry and Molecular Biology, Faculty of Medicine, The Hebrew University (Israel)
HIV co-opts the host antiviral response to enable splicing of its own mRNA
Alexander Hüttenhofer, PhD
Innsbruck Medical University – Biocenter, Innsbruck (Austria)
Yi Xing, PhD
Center for Computational and Genomic Medicine The Children’s Hospital of Philadelphia (USA)
Keynote Speakers
Michele Mishto, PhD
Centre for Inflammation Biology and Cancer Immunology (CIBCI) & Peter Gorer Department of Immunobiology, King’s College London, London (UK)
David Bates, PhD
Division of Cancer and Stem Cells,School of Medicine,University of Nottingham (UK)
Hui Li, PhD
School of Medicine, University of Virginia (USA)
Diana Baralle, PhD
University of Southampton, Southampton (UK)
Annette Lasham, PhD
University of Auckland, Auckland (New Zealand)
Long amplicon digital PCR to detect and quantitate alternatively-spliced TP53 transcripts
Jean-Pierre Perreaul, PhD
University of Sherbrooke, Québec (Canada)
RNA G-quadruplex as a key motif of intron retention
Matthias Soller, PhD
School of Biosciences, University of Birmingham, Birmingham (UK)
Mechanisms directing ELAV target specificity for alternative splicing
Nicholas Webster, PhD
Chief, Division of Endocrinology and Metabolism Associate Director for Shared Resources, Moores Cancer Center University of California, San Diego (USA)
J. Christopher States, PhD
Department of Pharmacology and Toxicology, University of Louisville School of Medicine (USA)
Dysregulation of mRNA splicing in a model for chronic arsenic exposure induced skin cancer
Symposium Subjects
- RNA Splicing
- Protein Splicing
- DNA Splicing
- Alternative Splicing
- Splicing and Disease
- Splicing and Nanotechnology
- Autosplicing
- Espliceosome
- Computacional Biology of Splicing
- Translational Applications
Costa da Caparica
Be aware of cold calls from Convention Hotel Services (CHS) or from someone named Adam Max! A company called CHS (Convention Hotel Services) is calling or e-mailing attendees of conferences worldwide, claiming to work for the conference organizers and asking for credit card details to finalize the booking of accommodation. If you receive such a call or e-mail, do not give away any personal information or credit card details! None of the parties involved in the organization of SPLICING 2023 is working with CHS
We have received some alerts from participants this week regarding this email: Ehotel Services via DocuSign
If you receive such a call or e-mail, do not give away any personal information or credit card details! This problem affects many conferences, not only the PROTEOMASS BIOSCOPE conferences.
We look forward to seeing you soon.
With kindest regards
The PROTEOMASS BIOSCOPE Team